Servier and NiKem Research Srl Enter into a Discovery Research Service Agreement
Servier and NiKem Research Srl announced the signature of a Discovery Research Service Agreement. Under the terms of the agreement NiKem will, in the next 12 months, use its medicinal chemistry experience, and its iterative and parallel chemistry platform, to design and synthesize drug-like kinase inhibitors aimed towards specific, undisclosed targets of interest for Servier. Financial terms of the agreement were not disclosed.
Most read news
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
NiKem Research receives certification for GLP Bioanalysis
Haemophilia_B
Aortic_insufficiency

New Detergents for Drug Research - So far, it is unclear why it is only possible to make intact membrane proteins available for drug research with the help of certain detergents
Personalized medicine: Functioning, induced liver cells from skin tissue - These cells can now be used to test therapeutic agents, among other things

Cholera bacteria form aggressive biofilm to kill immune cells - The study provides new insights into the infection strategies of pathogens
LifeSpan BioSciences to release 20,000 immunohistochemistry-validated reagent antibodies - Leader in antibody evaluation and validation expands focus to include development and sales of antibodies validated for use in immunohistochemistry

Could insulin come in a pill? - How a molecule that mimics insulin may advance diabetes research

Biomass production by reverse citric acid cycle - Central metabolic pathway runs "backwards" at high carbon dioxide concentrations
